Living-donor liver transplantation in patients with concurrent active tuberculosis at transplantation

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 8, 2010, Pages 1039-1044

  Lee, Y T ^a   Hwang, S ^a   Lee, S G ^a   Kim, K W ^a   Choi, N K ^a   Park, G C ^a   Yu, Y D ^a   Yoo, J W ^a   Kim, W S ^a   Shim, Tae Sun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Liver transplantation; Living donors; Tuberculosis

Indexed keywords

CYCLOSERINE; ETHAMBUTOL; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; LUNG; LUNG TUBERCULOSIS; LYMPH NODE; LYMPH NODE BIOPSY; MALE; OUTCOME ASSESSMENT; PLEURA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TUBERCULOUS LYMPHADENITIS; COMPARATIVE STUDY; COMPLICATION; INCIDENCE; ISOLATION AND PURIFICATION; KOREA; LIVER FAILURE, ACUTE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INCIDENCE; KOREA; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 77954694545     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Torre-Cisneros J, Caston J J, Moreno J, et al. Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation 2004; 77: 1376-1380. (Pubitemid 38668430)
2. Idilman R, Ersoz S, Coban S, Kumbasar O, Bozkaya H. Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy. Liver Transpl 2006; 12: 1427-1430. (Pubitemid 44405134)
3. Barcena R, Oton E, Angeles Moreno M, et al. Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis? Am J Transplant 2005; 5: 2796-2798.
4. Tost J R, Vidal R, Cayla J, Diaz-Cabanela D, Jimenez A, Broquetas J M. Severe hepatotoxicity due to anti-tuberculosis drugs in Spain. Int J Tuberc Lung Dis 2005; 9: 534-540. (Pubitemid 40646839)
5. Lee D S, Woo J G, Lee H H, et al. Auxiliary partial orthotopic liver transplantation in the treatment of acute liver failure: a case report. Transplant Proc 2004; 36: 2228-2229.
6. Kunimoto D, Warman A, Beckon A, Doering D, Melenka L. Severe hepatotoxicity associated with rifampin-pyrazinamide preventative therapy requiring transplantation in an individual at low risk for hepatotoxicity. Clin Infect Dis 2003; 36: e158-161.
7. Lee S G, Park K M, Hwang S, et al. Adult-to-adult living donor liver transplantation at the Asan Medical Center, Korea. Asian J Surg 2002; 25: 277-284. (Pubitemid 35429386)
8. Farrell F J, Keeffe E B, Man K M, Imperial J C, Esquivel C O. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci 1994; 39: 2255-2259. (Pubitemid 24341644)
9. Meyers B R, Halpern M, Sheiner P, et al. Acute hepatic failure in seven patients after prophylaxis and therapy with antituberculous agents. Successful treatment with orthotopic liver transplantation. Transplantation 1994; 58: 372-377.
10. Marra F, Cox V C, FitzGerald J M, Moadebi S, Elwood R K. Successful treatment of multidrug-resistant tuberculosis following drug-induced hepatic necrosis requiring liver transplant. Int J Tuberc Lung Dis 2004; 8: 905-909.
11. Wang B, Lu Y, Yu L, et al. Liver transplantation for patients with pulmonary tuberculosis. Transpl Infect Dis 2009; 11: 128-131.
12. Lew W J, Lee E G, Bai J Y, et al. An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis 2006; 10: 1241-1247.
13. Lee S G, Hwang S, Kim K H, et al. Toward 300 liver transplants a year. Surg Today 2009; 39: 367-373.
14. Jung H, Oh Y-M, Lee S, et al. Clinical characteristics of tuberculosis in liver or heart transplant recipients. Tuberc Respir Dis 2006; 61: 440-446. (Pubitemid 46333225)
15. Benito N, Sued O, Moreno A, et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation 2002; 74: 1381-1386. (Pubitemid 35379541)
16. Holty J E, Gould M K, Meinke L, Keeffe E B, Ruoss S J. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15: 894-906.
17. Chen C L, Fan S T, Lee S G, Makuuchi M, Tanaka K. Living-donor liver transplantation: 12 years of experience in Asia. Transplantation 2003; 75 (3 Suppl): S6-S11. (Pubitemid 36222979)
18. Aguado J M, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276-1284.
19. Aguado J M, Herrero J A, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63: 1278-1286. (Pubitemid 27212823)
20. Sinnott J T IV, Emmanuel P J. Mycobacterial infections in the transplant patient. Semin Respir Infect 1990; 5: 65-73.
21. Vachharajani T J, Oza U G, Phadke A G, Kirpalani A L. Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol. Int Urol Nephrol 2002; 34: 551-553. (Pubitemid 37235986)
22. Jha V, Sakhuja V. Rifampicin sparing treatment protocols in posttransplant tuberculosis. Int Urol Nephrol 2004; 36: 287-288. (Pubitemid 38961791)
23. Lopez-Montes A, Gallego E, Lopez E, et al. Treatment of tuberculosis with rifabutin in a renal transplant recipient. Am J Kidney Dis 2004; 44: e59-63. (Pubitemid 39237596)
24. Meyers B R, Papanicolaou G A, Sheiner P, Emre S, Miller C. Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens. Transplantation 2000; 69: 64-69. (Pubitemid 30062610)
25. Blumberg H M, Burman W J, Chaisson R E, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.